This article is a retraction of:
RETRACTED: MicroRNA-326 Functions as a Tumor Suppressor in Breast Cancer by Targeting ErbB/PI3K Signaling Pathway
A Retraction of the Original Research Article
MicroRNA-326 functions as a tumor suppressor in breast cancer by targeting ErbB/PI3K signaling pathway
by Ghaemi Z, Soltani BM and Mowla SJ (2019) Front. Oncol. 9:653. doi: 10.3389/fonc.2019.00653
Following publication, concerns were raised regarding the validity of the data in the article. The authors failed to provide the raw data and a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies. Given the concerns about the validity of the data, and the lack of raw data, the editors no longer have confidence in the findings presented in the article. This retraction was approved by the Chief Editors of Frontiers in Oncology.
The authors did not agree with the retraction.
Citation: Frontiers Editorial Office (2023) Retraction: MicroRNA-326 functions as a tumor suppressor in breast cancer by targeting ErbB/PI3K signaling pathway. Front. Oncol. 13:1298871. doi: 10.3389/fonc.2023.1298871
Received: 22 September 2023; Accepted: 27 September 2023;
Published: 10 October 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office, research.integrity@frontiersin.org